Table 2.
Follow-up characteristics of the study cohort
| Characteristic | Failure | p-value | |
|---|---|---|---|
| No (n = 387) | Yes (n = 152) | ||
| Anuria during follow-up | 0.076 | ||
| No | 289 (74.7%) | 102 (67.1%) | |
| Yes | 98 (25.3%) | 50 (32.9%) | |
| Follow-up time, months | 30 (21, 46) | 30 (15, 53) | 0.521 |
| Peritonitis | <0.001 | ||
| No | 329 (85.0%) | 100 (65.8%) | |
| Yes | 58 (15.0%) | 52 (34.2%) | |
| RKF slope, ml/min/1.73 m2/M | −0.13 (−0.20, −0.07) | −0.16 (−0.21, −0.11) | 0.008 |
Note: all values are presented as median (Q1, Q3) or as counts (n (%)). Baseline anuria excluded. Anuria during follow-up: 24 h urine volume < 100 ml. RKF slope: individual linear regression of measured glomerular filtration rate (mGFR) over time. Follow-up time: from PD initiation to event or censoring. RKF, residual kidney function